EP4212152
SACUBITRIL-VALSARTAN SKÖMMTUNARÁÆTLUN TIL MEÐFERÐAR VIÐ LANGVINNRI SLAGBILSHJARTABILUN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.5.2016EP published:
30.4.2025EP application number:
23154757.1
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
8.5.2036Expiry date:
8.5.2026Next due date:
31.5.2026
Title in English:
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURELanguage of the patent:
English
Timeline
Today
9.5.2016EP application
30.4.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
8.5.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
RIZKALA, Adel RedmondAddress:
East Hannover, 07936, US
Name:
SHI, Victor ChengweiAddress:
East Hanover, 07936, US
Name:
CHEN, FabianAddress:
East Hanover, 07936, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201562159703 PDate:
11.5.2015Country:
US
Classification
Categories:
A61K 31/225, A61K 31/41, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 26.6.2025
Expires: 8.5.2026
Payer: Árnason Faktor ehf.